Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB
· Real-Time Price · USD
6.04
-0.07 (-1.15%)
At close: Aug 18, 2025, 3:59 PM
6.19
2.57%
After-hours: Aug 18, 2025, 05:55 PM EDT
-1.15% (1D)
| Bid | 6 |
| Market Cap | 469.94M |
| Revenue (ttm) | 3.12M |
| Net Income (ttm) | -139.68M |
| EPS (ttm) | -2.79 |
| PE Ratio (ttm) | -2.16 |
| Forward PE | -2.91 |
| Analyst | Buy |
| Ask | 6.19 |
| Volume | 734,905 |
| Avg. Volume (20D) | 1,568,651 |
| Open | 6.15 |
| Previous Close | 6.11 |
| Day's Range | 6.03 - 6.28 |
| 52-Week Range | 2.41 - 10.37 |
| Beta | 2.44 |
About SLDB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SLDB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SLDB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 days ago
+10.6%
Solid Biosciences shares are trading higher after ...
Unlock content with
Pro Subscription
3 weeks ago
+8.51%
Solid Biosciences shares are trading higher after the company announced it received FDA Fast Track Designation status for SGT-501 gene therapy.
